Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
changes decrease » larger decrease (Expand Search), largest decrease (Expand Search), change increases (Expand Search)
shape increases » showed increases (Expand Search), sharp increase (Expand Search), disease increases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
changes decrease » larger decrease (Expand Search), largest decrease (Expand Search), change increases (Expand Search)
shape increases » showed increases (Expand Search), sharp increase (Expand Search), disease increases (Expand Search)
-
1821
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
1822
-
1823
-
1824
-
1825
-
1826
-
1827
-
1828
-
1829
-
1830
-
1831
-
1832
-
1833
-
1834
-
1835
Baseline characteristics and potential independent risk factors for mortality of SFTS.
Published 2025Subjects: -
1836
Kinetics of coagulation parameters between the survivors and non-survivors during hospitalization.
Published 2025Subjects: -
1837
-
1838
Restricted cubic spline models depicting the relationship between APTT and mortality risk in SFTS.
Published 2025Subjects: -
1839
-
1840